← All stocks

Royalty Pharma plc

RPRX No buying or selling
CIK 0001802768 #618 in the set updated 21 Sep 2026
Bought (1 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (1 mo)
$0.00
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 0 sales
Net
$0.00
$0.00 against sales at will

By person

15 insiders · 0 transactions
83.6×

Pablo Legorreta holds 83.6 times base salary in stock. $78.43M of shares against $937.50K in salary for 2025.

Salary from the company's own proxy. The shares are what Pablo Legorreta last reported holding, valued at $59.97, the price Class A Ordinary Shares was last bought or sold at on the open market here, on 18 Aug 2026.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Legorreta Pablo G.
CEO, Chairman of the Board
1,307,820
$78.43M
+1,950%
Hite Christopher
EVP & Chairman, Partnering
393,601
$23.61M
+6.4%
Norden Gregory
Director
196,348
$11.78M
+158.1%
DESOUZA ERROL B
Director
81,352
$4.88M
+10.3%
Bassler Bonnie L
Director
79,181
$4.75M
+35.5%
Fernandez Henry A
Director
65,324
$3.92M
+24.0%
LOVE TED W
Director
58,393
$3.50M
+26.3%
Engelbert Catherine M.
Director
55,673
$3.34M
+27.9%
HODGSON DAVID C
Director
37,873
$2.27M
+47.3%
Coric Vlad
Director
15,343
$920.16K
WEATHERMAN ELIZABETH H
Director
13,103
$785.82K
Urist Marshall
EVP, Research & Investments
8,252
$494.89K
−82.3%
Ho Carole
Director
4,545
$272.58K
Coyne Terrance P.
EVP & CFO
0
$0.00
−100.0%
Lloyd George W.
EVP, Investments & CLO
0
$0.00
−100.0%

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

Nothing of that kind in this period.

What was left out

Form 4 filings counted 0
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 0
History held since 17 Jun 2020